- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Resectable Non-small Cell Lung Cancer in United States
Total 4152 results
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellUnited States, United Kingdom
-
Yale UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; NextCure, Inc.RecruitingAdvanced Non-small Cell Lung CancerUnited States
-
Brown UniversityLifespanActive, not recruitingStage III Non-small-cell Lung CancerUnited States
-
Yale UniversityMerck Sharp & Dohme LLCCompletedNon-Small Cell Lung Cancer (NSCLC)United States
-
Check, Jerome H., M.D., Ph.D.Corcept TherapeuticsTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
University of RochesterCelgene CorporationWithdrawnNon-small Cell Lung Cancer, Stage IIIUnited States
-
Megan Daly, MDGenentech, Inc.Active, not recruitingStage I Non-Small Cell Lung CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterPeregrine PharmaceuticalsCompletedNon Small Cell Lung Cancer (NSCLC)United States
-
Stanford UniversityEli Lilly and Company; Genentech, Inc.CompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; Southwest Oncology... and other collaboratorsTerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States, Canada
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
M.D. Anderson Cancer CenterConquer Cancer FoundationActive, not recruitingNon-small Cell Lung CancerUnited States
-
Massachusetts General HospitalCompletedNon Small Cell Lung CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
Karen Reckamp, MD, MSEnviro Therapeutics, Inc.RecruitingLung Cancer | Non Small Cell Lung CancerUnited States
-
Teligene USRecruitingNon-small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminated
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedExtensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
AbelZeta, Inc.Nektar TherapeuticsRecruiting
-
Washington University School of MedicineApollomics Inc.RecruitingMetastatic Non Small Cell Lung CancerUnited States
-
Lyudmila Bazhenova, M.D.BeyondSpring Pharmaceuticals Inc.Active, not recruitingNon-small Cell Lung Cancer MetastaticUnited States
-
Albert Einstein College of MedicineCelldex TherapeuticsActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States
-
West Virginia UniversityWest Virginia Clinical and Translational Science InstituteCompletedNon Small Cell Lung Cancer MetastaticUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedStage IV Non-small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminatedAdvanced Non-Small Cell Lung CancerUnited States
-
The Cooper Health SystemUnknownUntreated Advanced Non-Small Cell Lung CancerUnited States
-
Duke UniversityCompletedA Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR MutationsNon Small Cell Lung CancerUnited States
-
Cell>Point LLCVenn Life Sciences; Biomedical Systems; Numoda; Camargo Pharmaceutical ServicesCompletedNon Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Minimal Residual Disease | NSCLC Stage IV | Nsclc | Metastatic Non Small Cell Lung CancerUnited States
-
Jeffrey ClarkeMerck Sharp & Dohme LLC; Grid TherapeuticsSuspendedNon Small Cell Lung Cancer | Metastatic NSCLC | Recurrent Non Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterEARLY LabsRecruiting
-
Vitrac Therapeutics, LLCWestatTerminatedNon-small Cell Lung CancerUnited States
-
Regeneron PharmaceuticalsNovella ClinicalCompletedNon Small Cell Lung CancerUnited States
-
Symphony Evolution, Inc.Terminated
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States
-
Muhammad FurqanBiodesix, Inc.TerminatedNon Small Cell Lung CancerUnited States
-
Addario Lung Cancer Medical InstituteWithdrawn
-
Albert Einstein College of MedicineMontefiore Medical CenterActive, not recruitingNon-small Cell Lung Cancer, NSCLCUnited States
-
University of California, DavisNovartis PharmaceuticalsCompletedSolid Tumors | Non-Small Cell Lung Cancer (NSCLC)United States
-
Integrated Community Oncology NetworkSanofiUnknownPreviously Treated Metastatic Non-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Bronchoalveolar Cell Lung Cancer | Large Cell Lung Cancer | Adenosquamous Cell Lung CancerUnited States
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8United States
-
University of NebraskaNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)RecruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
Regeneron PharmaceuticalsSanofiTerminatedNon-small Cell Lung CancerUnited States, Italy, Lithuania
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Resectable Lung Non-Small Cell Carcinoma | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
University of Texas Southwestern Medical CenterCompletedNon-small Cell Lung CancerUnited States